These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 8973589)

  • 1. Breast cancer prognostic significance of some modified urinary nucleosides.
    Sasco AJ; Rey F; Reynaud C; Bobin JY; Clavel M; Niveleau A
    Cancer Lett; 1996 Nov; 108(2):157-62. PubMed ID: 8973589
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monitoring of urinary excretion of modified nucleosides in cancer patients using a set of six monoclonal antibodies.
    Reynaud C; Bruno C; Boullanger P; Grange J; Barbesti S; Niveleau A
    Cancer Lett; 1992 Jan; 61(3):255-62. PubMed ID: 1739950
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship between urinary excretion of modified nucleosides and rheumatoid arthritis process.
    Tebib JG; Reynaud C; Cedoz JP; Letroublon MC; Niveleau A
    Br J Rheumatol; 1997 Sep; 36(9):990-5. PubMed ID: 9376997
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urinary nucleosides as biomarkers of breast, colon, lung, and gastric cancer in Taiwanese.
    Hsu WY; Chen CJ; Huang YC; Tsai FJ; Jeng LB; Lai CC
    PLoS One; 2013; 8(12):e81701. PubMed ID: 24367489
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nucleoside excretion in breast cancer: comparison with other biochemical tumour-index-substances.
    Coombes RC; Powles TJ; Gehrke CW; Waalkes TP; Neville AM
    Invest Cell Pathol; 1979; 2(1):11-4. PubMed ID: 511604
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Application of urinary nucleosides in the diagnosis and surgical monitoring of colorectal cancer].
    Feng B; Zheng MH; Zheng YF; Lu AG; Li JW; Wang ML; Ma JJ; Xu GW; Yu BM
    Zhonghua Wai Ke Za Zhi; 2005 May; 43(9):564-8. PubMed ID: 15938925
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitation of urinary nucleosides by high-performance liquid chromatography.
    Liebich HM; Di Stefano C; Wixforth A; Schmid HR
    J Chromatogr A; 1997 Feb; 763(1-2):193-7. PubMed ID: 9129323
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urinary modified nucleosides as tumor markers in cancer of the urinary organs or female genital tract.
    Koshida K; Harmenberg J; Stendahl U; Wahren B; Borgström E; Helström L; Andersson L
    Urol Res; 1985; 13(5):213-8. PubMed ID: 4060364
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circadian and chemotherapy-related changes in urinary modified nucleosides excretion in patients with metastatic colorectal cancer.
    Dulong S; Huang Q; Innominato PF; Karaboue A; Bouchahda M; Pruvost A; Théodoro F; Agrofoglio LA; Adam R; Finkenstädt B; Lévi F
    Sci Rep; 2021 Dec; 11(1):24015. PubMed ID: 34907230
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical significance and prognostic value of urinary nucleosides in breast cancer patients.
    Zheng YF; Kong HW; Xiong JH; Lv S; Xu GW
    Clin Biochem; 2005 Jan; 38(1):24-30. PubMed ID: 15607313
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Urinary excretion of six modified nucleosides by patients with breast carcinoma.
    Vreken P; Tavenier P
    Ann Clin Biochem; 1987 Nov; 24 ( Pt 6)():598-603. PubMed ID: 3426126
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modified nucleosides: an accurate tumour marker for clinical diagnosis of cancer, early detection and therapy control.
    Seidel A; Brunner S; Seidel P; Fritz GI; Herbarth O
    Br J Cancer; 2006 Jun; 94(11):1726-33. PubMed ID: 16685264
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Statistical-based approach in potential diagnostic application of urinary nucleosides in urogenital tract cancer.
    Daghir-Wojtkowiak E; Struck-Lewicka W; Waszczuk-Jankowska M; Markuszewski M; Kaliszan R; Markuszewski MJ
    Biomark Med; 2015; 9(6):577-95. PubMed ID: 26079962
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urinary excretion of modified purines and nucleosides in immunodeficient children.
    Mills GC; Schmalstieg FC; Goldblum RM
    Biochem Med; 1985 Aug; 34(1):37-51. PubMed ID: 4052062
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chromatographic, capillary electrophoretic and matrix-assisted laser desorption ionization time-of-flight mass spectrometry analysis of urinary modified nucleosides as tumor markers.
    Liebich HM; Müller-Hagedorn S; Klaus F; Meziane K; Kim KR; Frickenschmidt A; Kammerer B
    J Chromatogr A; 2005 Apr; 1071(1-2):271-5. PubMed ID: 15865203
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Excretion pattern investigation of urinary normal and modified nucleosides of breast cancer patients by RP-HPLC and factor analysis method.
    Xu G; Schmid HR; Lu X; Liebich HM; Lu P
    Biomed Chromatogr; 2000 Nov; 14(7):459-63. PubMed ID: 11113924
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An immunohistochemical analysis for cancer of the esophagus using monoclonal antibodies specific for modified nucleosides.
    Masuda M; Nishihira T; Itoh K; Mizugaki M; Ishida N; Mori S
    Cancer; 1993 Dec; 72(12):3571-8. PubMed ID: 8252470
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pyrimidine nucleoside, pseudouridine, and modified nucleoside excretion by growing and resting fibroblasts.
    Uziel M; Selkirk JK
    J Cell Physiol; 1979 May; 99(2):217-22. PubMed ID: 457787
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A quantitative approach to determining disease response during therapy using multiple biologic markers: application to carcinoma of the breast.
    Woo KB; Waalkes TP; Ahmann DL; Tormey DC; Gehrke CW; Oliverio VT
    Cancer; 1978 May; 41(5):1685-703. PubMed ID: 348295
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urinary modified nucleosides as novel biomarkers for diagnosis and prognostic monitoring of urothelial bladder cancer.
    Zhang YR; Shi L; Wu H; Tang DD; Wang SM; Liu HM; Zhang LR; Song DK
    Tumori; 2014; 100(6):660-6. PubMed ID: 25688500
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.